How We Measure Success

The Sabin Vaccine Institute focuses on a variety of measurements to demonstrate the impact and success of our work.  Some of the milestones we are working toward include:

Reducing the global prevalence of typhoid fever, pneumococcal disease, meningococcal disease, human papillomavirus, pertussis, polio, measles, rotavirus and rubella

Achieving World Health Organization pre-qualification for at least two typhoid vaccines

Promoting the creation of a supply and distribution system for two, first-ever dengue fever vaccines to be introduced over the next several years

Successfully implementing vaccine immunization finance legislation and funding mechanisms in at least 15 pilot countries

Bringing vaccine candidates for human hookworm, schistosomiasis and other NTDs through Phase 3 clinical trials, licensure and large scale manufacture

Increasing the level of awareness of the adverse impact of NTDs and what can be done to control them among general populations and policymakers

Promoting the creation and execution of national government, multi-year plans for NTD mass drug administration in all endemic countries

Encouraging greater integration between neglected tropical disease (NTD) control and other health programs such as water and sanitation, HIV/AIDS and malaria prevention programs

Mobilizing millions of dollars from G8/G20 governments and other sources to support NTD mass drug administration

Developing and institutionalizing regional funding mechanisms in Africa, Latin America and the Caribbean and Asia

Supporting ongoing pharmaceutical donation programs for vital NTD medicines and ensuring the effective use of these critical donations